Amgen Inc AMGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 05/16/24 EDT

314.72UNCH (UNCH)

Volume

113,599

314.72

+2.25 (+0.71%)

Volume

2,245,482

52 week range

211.71 - 329.72

Open314.63
Day High316.14
Day Low310.76
Prev Close314.72
52 Week High329.72
52 Week High Date02/05/24
52 Week Low211.71
52 Week Low Date06/01/23

Key Stats

Market Cap168.827B
Shares Out536.43M
10 Day Average Volume3.50M
Dividend9.00
Dividend Yield2.86%
Beta0.62
YTD % Change9.27

KEY STATS

Open314.63
Day High316.14
Day Low310.76
Prev Close314.72
52 Week High329.72
52 Week High Date02/05/24
52 Week Low211.71
52 Week Low Date06/01/23
Market Cap168.827B
Shares Out536.43M
10 Day Average Volume3.50M
Dividend9.00
Dividend Yield2.86%
Beta0.62
YTD % Change9.27

RATIOS/PROFITABILITY

EPS (TTM)7.00
P/E (TTM)44.97
Fwd P/E (NTM)16.23
EBITDA (TTM)11.625B
ROE (TTM)72.57%
Revenue (TTM)29.532B
Gross Margin (TTM)66.38%
Net Margin (TTM)12.74%
Debt To Equity (MRQ)1,274.79%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date05/16/2024
Div Amount2.25
Split Date-
Split Factor-

Latest On Amgen Inc

FDA approves Amgen's treatment for most deadly form of lung cancer 11 Hours AgoCNBC.com
Lilly falls on a rival's study — plus, we're removing 3 stocks from our watchlist 12 Hours AgoCNBC.com
Trade Tracker: Joe Terranova buys Amgen and MerckMay 15, 2024CNBC.com
Trade Tracker: Bill Baruch buys more Apple and AmgenMay 8, 2024CNBC.com
Dow pops more than 170 points to notch sixth positive day and longest win streak in 2024May 7, 2024CNBC.com

Content From Our Affiliates

Balancing Early Approval and Market Challenges: Amgen’s Imdelltra Receives a Hold Rating from Carter Gould8 Hours AgoTipRanks
Dow Jones (DJIA) Dominates in May: Here’s Why the Trend Could ContinueMay 9, 2024TipRanks
Amgen price target raised to $235 from $223 at MizuhoMay 9, 2024TipRanks
Wedbush upgrades CytomX to Outperform on ‘encouraging’ CX-904 Phase 1a dataMay 9, 2024TipRanks
Drugmakers work to make treatments to maintain weight loss, WSJ reportsMay 8, 2024TipRanks

Profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin...

Robert Bradway

Chairman of the Board, President, Chief Executive Officer

Peter Griffith

Chief Financial Officer, Executive Vice President

David Reese

Executive Vice President, Chief Technology Officer

Murdo Gordon

Executive Vice President - Global Commercial Operations

Lori Johnston

Executive Vice President - Human Resources

Address

One Amgen Center Drive

Thousand Oaks, CA

91320

United States

https://www.amgen.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
PFE Pfizer Inc	28.92	UNCH	UNCH
NVS Novartis AG	102.69	UNCH	UNCH
SNY Sanofi SA	48.82	UNCH	UNCH
GILD Gilead Sciences Inc	67.86	UNCH	UNCH
RHHBY Roche Holding AG	32.65	+1.25	+3.98%